Opko Health Stock Today
| OPK Stock | USD 1.64 0.08 4.65% |
PerformanceInsignificant
| Odds Of DistressBelow Average
|
Opko Health is selling for 1.64 as of the 26th of February 2025. This is a 4.65 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.63. Opko Health has about a 40 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of November 1995 | Category Healthcare | Classification Health Care |
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. The company has 672.8 M outstanding shares of which 88.64 M shares are now shorted by investors with about 34.81 days to cover. More on Opko Health
Moving against Opko Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Opko Stock Highlights
| President Chairman | Elias MD | ||||
| Old Name | OPKO Health Inc | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Tel Aviv 90, Tel Aviv 125, Dow Jones Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsOpko Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Opko Health's financial leverage. It provides some insight into what part of Opko Health's total assets is financed by creditors.
| |||||
Opko Health (OPK) is traded on NASDAQ Exchange in USA. It is located in 4400 Biscayne Boulevard, Miami, FL, United States, 33137 and employs 3,930 people. Opko Health is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 1.1 B. Opko Health runs under Biotechnology sector within Health Care industry. The entity has 672.8 M outstanding shares of which 88.64 M shares are now shorted by investors with about 34.81 days to cover.
Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.
Check Opko Health Probability Of Bankruptcy
Ownership AllocationOpko Health owns a total of 672.8 Million outstanding shares. Opko Health has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Opko Ownership Details
Opko Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 3.2 M | |
| Jane Street Group Llc | 2024-12-31 | 2.8 M | |
| Lazard Asset Management Llc | 2024-12-31 | 2.5 M | |
| Citadel Advisors Llc | 2024-09-30 | 2.5 M | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 2.3 M | |
| Two Sigma Investments Llc | 2024-12-31 | 1.6 M | |
| Amvescap Plc. | 2024-12-31 | 1.6 M | |
| Altshuler Shaham Ltd | 2024-12-31 | 1.4 M | |
| Y.d. More Investments Ltd | 2024-12-31 | 1.4 M | |
| Rubric Capital Management Lp | 2024-12-31 | 48.7 M | |
| Vanguard Group Inc | 2024-12-31 | 29.2 M |
Opko Health Historical Income Statement
Opko Stock Against Markets
Opko Health Corporate Executives
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Logal | CFO, Chief Accounting Officer, Sr. VP and Treasurer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.